Synlogic™ Inc. Company Profile

06:48 EDT 26th June 2019 | BioPortfolio

Synlogic™ is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, pioneering the development of a novel class of therapeutics, called Synthetic Biotics™, based on its proprietary synthetic biology and microbiome platform. Synlogic’s two lead therapeutic programs are being developed for the potential treatment of rare inborn errors of metabolism of Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). In addition to the company’s proprietary pipeline focused on rare diseases, the company is leveraging the broad potential of its Synthetic Biotics platform for novel drug development in major disease areas, such as metabolic and immunomodulatory diseases, through partnerships with pharmaceutical and biotechnology companies. Synlogic is collaborating with AbbVie to develop Synthetic Biotics-based treatment for inflammatory bowel disease (IBD). Synlogic is backed by leading life sciences investors, including Atlas Venture, New Enterprise Associates (NEA), Orbimed, Deerfield and the Bill & Melinda Gates Foundation. For more information, please visit

News Articles [44 Associated News Articles listed on BioPortfolio]

Synlogic and Roche Partner for Immuno-Oncology Combination Therapy for Solid Tumors

Synlogic is partnering with Roche to develop Synlogic’s SYNB1891 with Roche’s checkpoint inhibitor Tecentriq (atezolizumab) in advanced solid tumors.

Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D

[Updated 10:42 a.m., see below.] Synlogic, a developer of so-called “living medicines” comprised of engineered bacteria, is teaming up with synthetic biology company Ginkgo Bioworks in an effort t...

Synlogic and Ginkgo Bioworks to develop biotic drugs

Synlogic has entered a platform collaboration with biotech company Ginkgo Bioworks to support its synthetic bionic medicines pipeline. The alliance...Read More... The post Synlogic and Ginkgo Bioworks...

Janssen’s Scott Plevy Joins Synlogic as Chief Scientific Officer

Synlogic (NASDAQ: SYBX) has appointed Scott Plevy to serve as chief scientific officer. A gastroenterologist, Plevy was most recently a vice president in gastroenterology disease at Janssen Research &...

Of Microbes And Men

This blog was written by Aoife Brennan, CEO of Synlogic Therapeutics, as part of the From The Trenches feature of LifeSciVC. I am the CEO of Synlogic, a synthetic biology company, where the focus of o...

Synlogic, Ginkgo Bioworks Launch Platform Collaboration to Develop “Synthetic Biotic” Treatments

Synlogic will use Ginkgo Bioworks’ cell programming platform to expand and further develop a pipeline of novel “living” medicines based on engineered probiotics, building upon a 1½-year-old col...

Synlogic and Ginkgo Bioworks Enter Platform Collaboration for Accelerated Development of Novel Synthetic Biotic Medicines

CAMBRIDGE, Mass. & BOSTON–(BUSINESS WIRE)–Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to beneficial microbes to develop novel, living medicines ...

Synlogic to combine Synthetic Biotic SYNB1891 with Roche’s Tecentriq

Synlogic Inc. seeks to combine its preclinical dual innate immune activator SYNB1891 with Roche’s PD-L1 antagonist Tecentriq (atezolizumab) in advanced solid tumors.

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

Synlogic, Inc.

Synlogic is a private, biotechnology company, based in Cambridge, Massachusetts focused on delivering the potential of next generation synthetic biology to patients. Synlogic leve...

Synlogic™ Inc.

Synlogic™ is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, pioneering the development of a novel class of therapeutics, called Synthetic Bioti...

Synlogic, Inc. and Mirna Therapeutics, Inc.

More Information about "Synlogic™ Inc." on BioPortfolio

We have published hundreds of Synlogic™ Inc. news stories on BioPortfolio along with dozens of Synlogic™ Inc. Clinical Trials and PubMed Articles about Synlogic™ Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synlogic™ Inc. Companies in our database. You can also find out about relevant Synlogic™ Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record